These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 35249557)
1. Antidepressant prescribing for adult people with an intellectual disability living in England. Branford D; Shankar R Br J Psychiatry; 2022 Aug; 221(2):488-493. PubMed ID: 35249557 [TBL] [Abstract][Full Text] [Related]
2. Antiseizure medications prescribing for behavioural and psychiatric concerns in adults with an intellectual disability living in England. Branford D; Sun JJ; Shankar R Br J Psychiatry; 2023 May; 222(5):191-195. PubMed ID: 36786124 [TBL] [Abstract][Full Text] [Related]
3. Psychotropic prescribing in people with intellectual disability and challenging behaviour. Sheehan R; Strydom A; Morant N; Pappa E; Hassiotis A BMJ; 2017 Aug; 358():j3896. PubMed ID: 28821479 [No Abstract] [Full Text] [Related]
4. Management of psychotropic medications in adults with intellectual disability: a scoping review. Costello A; Hudson E; Morrissey S; Sharma D; Kelly D; Doody O Ann Med; 2022 Dec; 54(1):2486-2499. PubMed ID: 36120887 [TBL] [Abstract][Full Text] [Related]
5. Antipsychotic and antidepressant prescribing for 704 297 children and young people with and without intellectual disabilities: record linkage study. Henderson A; Kinnear D; Fleming M; Stanley B; Greenlaw N; Young-Southward G; Pell JP; Cooper SA Br J Psychiatry; 2021 Jan; 218(1):58-62. PubMed ID: 33541472 [TBL] [Abstract][Full Text] [Related]
6. [Psychotropic Prescribing Practices for Children and Adolescents with Intellectual Disabilities: A Cohort Study Using a Large-scale Health Insurance Database]. Inoue Y; Okumura Y; Fujita J Seishin Shinkeigaku Zasshi; 2016; 118(11):823-833. PubMed ID: 30620838 [TBL] [Abstract][Full Text] [Related]
7. Central nervous system medication use in older adults with intellectual disability: Results from the successful ageing in intellectual disability study. Chitty KM; Evans E; Torr JJ; Iacono T; Brodaty H; Sachdev P; Trollor JN Aust N Z J Psychiatry; 2016 Apr; 50(4):352-62. PubMed ID: 26019276 [TBL] [Abstract][Full Text] [Related]
8. Use of psychotropic medications in adults with intellectual disability: A systematic review and meta-analysis. Song M; Rubin BS; Ha JW; Ware RS; Doan TN; Harley D Aust N Z J Psychiatry; 2023 May; 57(5):661-674. PubMed ID: 36700564 [TBL] [Abstract][Full Text] [Related]
9. Psychotropic prescribing for persons with intellectual disabilities and other psychiatric disorders. Edelsohn GA; Schuster JM; Castelnovo K; Terhorst L; Parthasarathy M Psychiatr Serv; 2014 Feb; 65(2):201-7. PubMed ID: 24233105 [TBL] [Abstract][Full Text] [Related]
10. Characteristics and the trajectory of psychotropic medication use in general and antipsychotics in particular among adults with an intellectual disability who exhibit aggressive behaviour. Deb S; Unwin G; Deb T J Intellect Disabil Res; 2015 Jan; 59(1):11-25. PubMed ID: 24450426 [TBL] [Abstract][Full Text] [Related]
11. Structured Medication Review to Improve Pharmacotherapy in People with Intellectual Disability and Behavioural Problems. Scheifes A; Egberts TC; Stolker JJ; Nijman HL; Heerdink ER J Appl Res Intellect Disabil; 2016 Jul; 29(4):346-55. PubMed ID: 25882186 [TBL] [Abstract][Full Text] [Related]
12. [Practical guidelines for prescribing psychotropic medication to people with intellectual disability]. de Kuijper G; Degraeve G; Zinkstok JR Tijdschr Psychiatr; 2019; 61(11):786-791. PubMed ID: 31907889 [TBL] [Abstract][Full Text] [Related]
13. Changes over a decade in psychotropic prescribing for people with intellectual disabilities: prospective cohort study. Henderson A; Mcskimming P; Kinnear D; McCowan C; McIntosh A; Allan L; Cooper SA BMJ Open; 2020 Sep; 10(9):e036862. PubMed ID: 32912946 [TBL] [Abstract][Full Text] [Related]
14. Psychotropic medication use in adolescents with intellectual disability living in the community. Doan T; Ware R; McPherson L; van Dooren K; Bain C; Carrington S; Einfeld S; Tonge B; Lennox N Pharmacoepidemiol Drug Saf; 2014 Jan; 23(1):69-76. PubMed ID: 23929635 [TBL] [Abstract][Full Text] [Related]
15. A study of the prescribing for people with learning disabilities living in the community and in National Health Service care. Branford D J Intellect Disabil Res; 1994 Dec; 38 ( Pt 6)():577-86. PubMed ID: 7881229 [TBL] [Abstract][Full Text] [Related]
16. Mental illness, challenging behaviour, and psychotropic drug prescribing in people with intellectual disability: UK population based cohort study. Sheehan R; Hassiotis A; Walters K; Osborn D; Strydom A; Horsfall L BMJ; 2015 Sep; 351():h4326. PubMed ID: 26330451 [TBL] [Abstract][Full Text] [Related]
17. Predictors of Psychotropic Polypharmacy Among Outpatients With Psychiatric Disorders and Intellectual Disability. Lunsky Y; Modi M Psychiatr Serv; 2018 Feb; 69(2):242-246. PubMed ID: 29089006 [TBL] [Abstract][Full Text] [Related]
18. Trends in the use of psychotropic drugs in people with intellectual disability in Taiwan: a nationwide outpatient service study, 1997-2007. Hsu SW; Chiang PH; Chang YC; Lin JD; Tung HJ; Chen CY Res Dev Disabil; 2014 Feb; 35(2):364-72. PubMed ID: 24333807 [TBL] [Abstract][Full Text] [Related]
19. Prevalence and appropriateness of psychotropic medication prescribing in a nationally representative cross-sectional survey of male and female prisoners in England. Hassan L; Senior J; Webb RT; Frisher M; Tully MP; While D; Shaw JJ BMC Psychiatry; 2016 Oct; 16(1):346. PubMed ID: 27724879 [TBL] [Abstract][Full Text] [Related]
20. Relationship between anti-seizure medication and behaviors that challenge in older persons with intellectual disability and epilepsy: a review. Moon S; Watkins L; O'Dwyer M; Shankar R Expert Rev Neurother; 2024 Nov; 24(11):1097-1105. PubMed ID: 39160772 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]